Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

664
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
664
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

469
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
469
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

586
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
586
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

552
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
552
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

776
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
776
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

381
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
381

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Smartwatch-Derived Nocturnal Scratching Metrics Capture Disease Activity and Severity in Pediatric Atopic Dermatitis.

Journal of clinical medicine·2026
Same author

Cardiac conduction system malformations in heterotaxy result from dysregulated Pitx2 expression.

JCI insight·2026
Same author

[Two Cases of Appendiceal Goblet Cell Adenocarcinoma].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same author

Diagnostic potential of allergen-specific lymphocyte stimulation test in hen's egg yolk-induced, food protein-induced enterocolitis syndrome.

The journal of allergy and clinical immunology. Global·2025
Same author

Impact of Financial Burden on Family Caregivers of Older Adults Using Long-Term Care Insurance Services.

SAGE open nursing·2025
Same author

Reconstruction of left pulmonary vein using the left atrial appendage after resection of the common trunk.

JTCVS techniques·2025

Related Experiment Video

Updated: Apr 6, 2026

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

4.5K

[Treatment for the Postinfarction Ventricular Defect].

Takahiro Nishida1, Ryuji Tominaga

  • 1Department of Cardiovascular Surgery, Kyushu University School of Medicine, Fukuoka, Japan.

Kyobu Geka. the Japanese Journal of Thoracic Surgery
|July 23, 2015
PubMed
Summary
This summary is machine-generated.

Postinfarction ventricular septal defect (PIVSD) is a severe condition often requiring emergency surgery with high mortality. Percutaneous closure using the Amplatzer PIVSD device offers a potential treatment for high-risk patients.

More Related Videos

Reduction of Iatrogenic Atrial Septal Defects with an Anterior and Inferior Transseptal Puncture Site when Operating the Cryoballoon Ablation Catheter
08:00

Reduction of Iatrogenic Atrial Septal Defects with an Anterior and Inferior Transseptal Puncture Site when Operating the Cryoballoon Ablation Catheter

Published on: June 15, 2015

14.6K
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

4.5K

Related Experiment Videos

Last Updated: Apr 6, 2026

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

4.5K
Reduction of Iatrogenic Atrial Septal Defects with an Anterior and Inferior Transseptal Puncture Site when Operating the Cryoballoon Ablation Catheter
08:00

Reduction of Iatrogenic Atrial Septal Defects with an Anterior and Inferior Transseptal Puncture Site when Operating the Cryoballoon Ablation Catheter

Published on: June 15, 2015

14.6K
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

4.5K

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Medical Devices

Context:

  • Postinfarction ventricular septal defect (PIVSD) is a rare but critical complication following myocardial infarction.
  • Traditional surgical repair of PIVSD is associated with high mortality rates due to severe hemodynamic instability.
  • The exclusion method, introduced in 1990, has not significantly improved operative outcomes.

Purpose:

  • To evaluate the efficacy of percutaneous closure for postinfarction ventricular septal defects (PIVSD).
  • To assess the Amplatzer PIVSD device as a treatment option for patients with PIVSD.

Summary:

  • Postinfarction ventricular septal defect (PIVSD) presents a significant surgical challenge with historically poor outcomes.
  • A 2012 report indicated a 26.7% hospital mortality rate for acute PIVSD.
  • Percutaneous closure with the Amplatzer PIVSD device is explored as a viable alternative for high-risk individuals.

Impact:

  • Percutaneous closure may offer a less invasive and potentially life-saving option for extremely poor-risk PIVSD patients.
  • This approach could reduce the morbidity and mortality associated with PIVSD.
  • The study highlights a shift towards interventional techniques for complex cardiac defects.